Idaho Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Pfizer, Inc. (NY: PFE)
29.30 USD  +0.52 (+1.81%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Pfizer, Inc.
 
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Futures Set for Fourth-Straight Day of Gains
March 13, 2009
Stock futures were pointing higher on Friday, as Wall Street looked to extend the stock market's gains for the fourth straight session. Read More
category Markets
from FOXBusiness.com
Futures Set for Fourth-Straight Day of Gains
March 13, 2009
Stock futures were pointing higher on Friday, as Wall Street looked to extend the stock market's gains for the fourth straight session. Read More
category Markets
from FOXBusiness.com
Roche Takes Genentech
March 12, 2009
Roche’s $46.8 billion takeover of Genentech (DNA) will give the Swiss company control of Avastin and Herceptin  promising cancer treatments. The bet: Results on Avastin’s clinical trials for early... Read More
category Trading Ideas
from Minyanville Headlines
GM, Citi stock drops raise doubts about Dow industrials make-up
March 12, 2009
In a sign of the times, the relevance and composition of the Dow Jones Industrial Average, the most popular window into Wall Street for retail investors, is increasingly being questioned now that five... Read More
category GE , GM , Financial Services , and 21 more.
from MarketWatch
Pfizer Rallies on Pancreatic Tumor Drug Trial Results (PFE)
March 12, 2009
Shares of Pfizer (PFE) are up 6% in early trading after the drug company said its cancer drug Sutent met goals against pancreas tumors during recent trials. The company tested Sutent for patients with... Read More
category TOP STORY , pfe , Dividend Stocks
from Dividend Daily
Why A Merck/Schering Combo Makes Sense (MRK)
March 12, 2009
The Merck/Schering marriage might be a winning combination for both the companies and investors. Read More
from Investopedia Advisor Commentary
Morning Movers 3/12: CV Therapeutics (CVTX) Surges On Buyout, GE (GE) Up On Rating Cut/Stable Outlook
March 12, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4481131 for the full story. Read More
from StreetInsider.com News Articles
Gilead falls, Pfizer climbs in early trading
March 12, 2009
Drug stocks edged higher early Thursday while shares of Gilead Sciences fell on news that it plans to acquire CV Therapeutics for $1.4 billion. Read More
category Market News , Biotechnology , DNA , and 10 more.
from MarketWatch
Gilead to buy CV Therapeutics for $1.4 billion
March 12, 2009
Gilead Sciences agrees to acquire CV Therapeutics for $1.4 billion, marking just the latest in a recent flurry of drug-industry mergers. The acquisition premium works out to 25%. Read More
category SGP , Biotechnology , DNA , and 10 more.
from MarketWatch
Pfizer rises on positive drug news for cancer drug Sutent
March 12, 2009
Pharmaceutical giant Pfizer Inc. said early Thursday that a late-stage clinical trial has shown its oncology drug Sutent to be effective in slowing the progression of advanced pancreatic cancer. Read More
category Company Announcements , Biotechnology , WYE , and 1 more.
from MarketWatch
Pfizer (PFE) Announces Sutent Significantly Increases Progression Free Survival for Patients with Pancreatic Cancer; Study Halted Early
March 12, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4480474 for the full story. Read More
from StreetInsider.com News Articles
U.S. stock futures point to opening dip after two days of gains
March 12, 2009
U.S. stock futures head only mildly south on Wall Street Thursday, with indexes overseas lower on the view a sustained turnaround for stocks can't be called yet, while Genentech agreed to a buyout... Read More
category Market News , DNA , RHHDY , and 5 more.
from MarketWatch
Genentech accepts Roche bid at $95 a share
March 12, 2009
Roche and Genentech end their protracted takeover effort with a friendly accord under which the Basel health care major will pay $95 a share for the 44% of the South San Francisco biotech giant it... Read More
category SGP , Biotechnology , DNA , and 9 more.
from MarketWatch
Asia's Dividend Harvest
March 12, 2009
Jesper Madsen , manager of Matthews Asia Pacific Equity Income Fund, sees many advantages in buying dividend-paying Asian stocks now. Read More
from MoneyShow.com
Healthcare bond issuance surges on drug M&A
March 09, 2009
SAN FRANCISCO (MarketWatch) - Drug companies have rushed to tap the capital markets this year as they take part in an acquisition spree, pushing U.S. healthcare bond issuance up 9 times from year-ago... Read More
category SGP , CH:ROG , DNA , and 10 more.
from MarketWatch
Big TARP recipients lead loan rankings this year
March 09, 2009
Citigroup, Bank of America and J.P. Morgan Chase, which have received more than $100 billion in government support, are the leading arrangers of loans so far this year, Dealogic data show. Read More
category UK:BARC , Financial Services , Banks , and 17 more.
from MarketWatch
Genentech in Talks to Merge With Roche: WSJ
March 09, 2009
Genentech is in talks about a possible merger with Swiss drug giant Roche, the WSJ reported. Read More
category Health Care
from FOXBusiness.com
Morning Watch, March 9
March 09, 2009
Merger news not enough to push futures higher as losses in global markets provides a bearish tone. Read More
from Optionetics
Rodman & Renshaw Resumes Coverage on MannKind (MNKD) with a Market Outperform
March 09, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4469627 for the full story. Read More
from StreetInsider.com News Articles
Merck, Schering-Plough merger fails to stoke sector
March 09, 2009
News that U.S. drugmakers Merck & Co. and Schering-Plough Corp. plan to merge do little to stoke trading in the sector early Monday, as the benchmark indexes for both the biotech and pharmaceutical... Read More
category Biotechnology , ASTM , M&A , and 15 more.
from MarketWatch
MannKind (MNKD) to Purchase Pfizer's (PFE) Frankfurt Insulin Manufacturing Plant for $33M
March 09, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4468597 for the full story. Read More
from StreetInsider.com News Articles
MannKind To Acquire Insulin Facility From Pfizer
March 09, 2009
MannKind To Acquire Insulin Facility From Pfizer Read More
category Health Care
from FOXBusiness.com
Futures Fall after World Bank report, Schering-Plough Shares Jump
March 09, 2009
Wall Street was looking at a negative open Monday after the World Bank issued a report that forecasted that the global economy will contract in 2009 for the first time since World War II. Read More
category Markets
from FOXBusiness.com
Futures Fall after World Bank report, Schering-Plough Shares Jump
March 09, 2009
Wall Street was looking at a negative open Monday after the World Bank issued a report that forecasted that the global economy will contract in 2009 for the first time since World War II. Read More
category Markets
from FOXBusiness.com
Monday's biggest gaining and declining stocks
March 09, 2009
Among the companies whose shares are expected to see active trade in Monday's session are AT&T, Elan, Genta, McClatchy, Merck, Northrop Grumman, Schering-Plough, Sterlite, Vedanta and Watson Pharma. Read More
category GNTA , UK:LLOY , T , and 28 more.
from MarketWatch
Merck inks deal to buy Schering-Plough for $41.1 billion
March 09, 2009
Pharmaceutical giant Merck & Co., Inc on Monday says it will buy rival Schering-Plough for $41.1 billion in cash and shares to expand its presence in emerging markets and bolster its pipeline of... Read More
category SGP , Pharmaceuticals , MRK , and 3 more.
from MarketWatch
Dividend Cuts Are Most Unkind To Income-oriented Investors
March 08, 2009
Dividend Cuts Are Most Unkind To Income-oriented Investors Read More
category Finance
from FOXBusiness.com
Dividend cuts are most unkind to income-oriented investors
March 08, 2009
Corporate dividends were once sacred, but no longer. As the economy declines, so have the regular cash payouts that both companies and stockholders considered untouchable. Read More
category VDIGX , MON , DLN , and 23 more.
from MarketWatch
Freaky Friday Potpourri: Darkness Before the Dawn
March 06, 2009
It still feels foreign to step away from the fray during market hours yet that's precisely what I did yesterday afternoon. Between a dizzying array of e-mails incessant information assimilation and the... Read More
category News and Views
from Minyanville Headlines
Notable Analyst Rating Changes 3/5: BIDU, T, ADBE, SIGM Upgraded; CXR, RIO, GPS Downgraded
March 05, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4462244 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here